Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed attachment file name file name title title question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label attachment file name title
tabling member	label

Search

422699

	registered interest
	date	20/10/2015
	answering body	Ministry of Justice
	answering dept id	54
	answering dept short name	Justice
	answering dept sort name	Justice
	hansard heading	Domestic Abuse: Prosecutions
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Justice, if he will assess the efficacy of the communication between the criminal courts and the family courts where a prosecution for domestic abuse is happening alongside child contact proceedings.
	tabling member constituency	Lewisham, Deptford
	tabling member printed	Vicky Foxcroft
	uin	12605
	answer	answer is ministerial correction date of answer 28/10/2015 answer text <p><del class="ministerial">The Ministry of Justice does not collect information centrally on Litigants in Person, or on who is cross examining witnesses in family court cases.</del></p><br /><p><ins class="ministerial">The Government takes the issue of domestic violence extremely seriously. A number of recent measures have been taken to strengthen and clarify the family court’s response to issues of domestic violence.</ins></p><br /><p><ins class="ministerial">Where criminal and <a href="http://www.cps.gov.uk/publications/prosecution/domestic/domv.html#a10" target="_blank">civil proceedings</a> are taking place at the same time, prosecutors will ensure that the court has the appropriate information to enable them to make other orders that prioritise the safety of victims, children and young people.</ins></p><br /><p><ins class="ministerial">Guidance to the family court makes clear that if domestic violence is alleged, the court must take this is into account when making decisions about contact with a child and the welfare of the child is of paramount importance.</ins></p><p><br /><ins class="ministerial"> Her Majesty’s Courts &amp; Tribunal Services (HMCTS) are constantly looking for ways to improve the service that they offer to victims and witnesses. This includes making the appropriate links between family court proceedings and the criminal justice system.</ins></p><br /> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 28/10/2015 13:17:50 question first ministerially corrected 28/10/2015 18:28:09 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 26151 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4491 label Biography information for Vicky Foxcroft

176781

	registered interest
	date	29/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether joint committees of NHS England and clinical commissioning groups are permitted to deviate from national service specifications for specialised services.
	tabling member constituency	Walsall South
	tabling member printed	Valerie Vaz
	uin	222695
	answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England is the accountable commissioner and budget holder for all specialised services as set out in The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the Manual for prescribed specialised services providing further detail.</p><p> </p><p> </p><p> </p><p>NHS England has achieved significant progress in developing a set of nationally consistent service standards and commissioning policies, which ensure equity of access to high quality services across the board. Those standards and policies will continue to apply for those specialised services which are to be collaboratively commissioned by NHS England and clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England is currently in the process of agreeing the guidance on the collaborative commissioning arrangements which will be in place from 1 April 2015.</p><p> </p><p> </p><p> </p><p>NHS England has clarified that where there are collaboratively commissioned services, NHS England will retain the full financial risk for these services for 2015/16. NHS England has advised us that there will be further work conducted over the next year to advise on the range of specialised services for which NHS England should remain the accountable commissioner and budget holder for 2016/17 and future years.</p><p> </p><p> </p><p> </p><p>Copies of The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 and the Manual for prescribed specialised services are attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison attachment 1 file name nhs-england-and-ccg-regulations.pdf title Regulations NHS Commissioning Board & CCGs 2 file name pss-manual.pdf title Manual prescribed specialised services question first answered 03/02/2015 15:09:14 question first ministerially corrected 03/02/2015 15:20:37 answering member 3918 label Biography information for Jane Ellison previous answer version 42619 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	4076 label Biography information for Valerie Vaz

176783

	registered interest
	date	29/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when NHS England will publish details of the co-commissioning of specialised services.
	tabling member constituency	Walsall South
	tabling member printed	Valerie Vaz
	uin	222693
	answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England is the accountable commissioner and budget holder for all specialised services as set out in The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the Manual for prescribed specialised services providing further detail.</p><p> </p><p> </p><p> </p><p>NHS England has achieved significant progress in developing a set of nationally consistent service standards and commissioning policies, which ensure equity of access to high quality services across the board. Those standards and policies will continue to apply for those specialised services which are to be collaboratively commissioned by NHS England and clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England is currently in the process of agreeing the guidance on the collaborative commissioning arrangements which will be in place from 1 April 2015.</p><p> </p><p> </p><p> </p><p>NHS England has clarified that where there are collaboratively commissioned services, NHS England will retain the full financial risk for these services for 2015/16. NHS England has advised us that there will be further work conducted over the next year to advise on the range of specialised services for which NHS England should remain the accountable commissioner and budget holder for 2016/17 and future years.</p><p> </p><p> </p><p> </p><p>Copies of The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 and the Manual for prescribed specialised services are attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison attachment 1 file name nhs-england-and-ccg-regulations.pdf title Regulations NHS Commissioning Board & CCGs 2 file name pss-manual.pdf title Manual prescribed specialised services question first answered 03/02/2015 15:09:14 question first ministerially corrected 03/02/2015 15:21:10 answering member 3918 label Biography information for Jane Ellison previous answer version 42620 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	4076 label Biography information for Valerie Vaz

176784

	registered interest
	date	29/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether NHS England will remain the sole budget-holder and accountable commissioner for all specialised services.
	tabling member constituency	Walsall South
	tabling member printed	Valerie Vaz
	uin	222694
	answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England is the accountable commissioner and budget holder for all specialised services as set out in The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the Manual for prescribed specialised services providing further detail.</p><p> </p><p> </p><p> </p><p>NHS England has achieved significant progress in developing a set of nationally consistent service standards and commissioning policies, which ensure equity of access to high quality services across the board. Those standards and policies will continue to apply for those specialised services which are to be collaboratively commissioned by NHS England and clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England is currently in the process of agreeing the guidance on the collaborative commissioning arrangements which will be in place from 1 April 2015.</p><p> </p><p> </p><p> </p><p>NHS England has clarified that where there are collaboratively commissioned services, NHS England will retain the full financial risk for these services for 2015/16. NHS England has advised us that there will be further work conducted over the next year to advise on the range of specialised services for which NHS England should remain the accountable commissioner and budget holder for 2016/17 and future years.</p><p> </p><p> </p><p> </p><p>Copies of The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 and the Manual for prescribed specialised services are attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison attachment 1 file name nhs-england-and-ccg-regulations.pdf title Regulations NHS Commissioning Board & CCGs 2 file name pss-manual.pdf title Manual prescribed specialised services question first answered 03/02/2015 15:09:14 question first ministerially corrected 03/02/2015 15:23:29 answering member 3918 label Biography information for Jane Ellison previous answer version 42621 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	4076 label Biography information for Valerie Vaz

388300

	registered interest
	date	07/07/2015
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	hansard heading	Passports: British Nationals Abroad
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, what (a) number and (b) proportion of applications for a passport for a child overseas take longer than (a) three, (b) four and (c) six months to be processed.
	tabling member constituency	Edinburgh East
	tabling member printed	Tommy Sheppard
	uin	5846
	answer	answer is ministerial correction date of answer 15/07/2015 answer text <p>A total of 49,173 international child passport applications finished processing in January-June 2015. Of this total, <del class="ministerial">2,418 (4.9%)</del> <ins class="ministerial">3,242 (6.6%)</ins> took longer than three months to be processed, <del class="ministerial">1,780 (3.6%)</del> <ins class="ministerial">2,539 (5.2%)</ins> took longer than four months to be processed, and <del class="ministerial">944 (1.9%)</del> <ins class="ministerial">1,657 (3.4%)</ins> took longer than six months to be processed.</p><p>The processing time is the length of time from receipt of the application to the passport being printed. For international child passport applications processed in the same period, the average processing time was 19.4 working days. Information is not held on the time between receipt of application and interview date as the date of interview can be subject to customer availability.</p><p>Her Majesty’s Passport Office must be fully satisfied that all appropriate checks have been completed successfully prior to the issuance of passport facilities. This is particularly important in relation to child applications as part of Her Majesty’s Passport Office responsibility to protect potentially vulnerable children, including those potentially at risk of child trafficking and to maintain the integrity of the British Passport.</p><p>These checks can require the provision of information from other agencies overseas – particularly in complex applications such as surrogacy cases.</p><p>Delays in the provision of this information to HMPO can lead to significantly extended timeframe in processing applications.</p><p> </p><p> </p> answering member constituency Old Bexley and Sidcup answering member printed James Brokenshire question first answered 15/07/2015 15:19:26 question first ministerially corrected 05/08/2015 13:22:11 answering member 1530 label Biography information for James Brokenshire previous answer version 14230 answering member constituency Old Bexley and Sidcup answering member printed James Brokenshire answering member 1530 label Biography information for James Brokenshire
	tabling member	4453 label Biography information for Tommy Sheppard

388302

	registered interest
	date	07/07/2015
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	hansard heading	Passports: British Nationals Abroad
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, what the average time is for processing a passport application for a child overseas from the initial application to the interview in connection with that application.
	tabling member constituency	Edinburgh East
	tabling member printed	Tommy Sheppard
	uin	5848
	answer	answer is ministerial correction date of answer 15/07/2015 answer text <p>A total of 49,173 international child passport applications finished processing in January-June 2015. Of this total, <del class="ministerial">2,418 (4.9%)</del> <ins class="ministerial">3,242 (6.6%)</ins> took longer than three months to be processed, <del class="ministerial">1,780 (3.6%)</del> <ins class="ministerial">2,539 (5.2%)</ins> took longer than four months to be processed, and <del class="ministerial">944 (1.9%)</del> <ins class="ministerial">1,657 (3.4%)</ins> took longer than six months to be processed.</p><p>The processing time is the length of time from receipt of the application to the passport being printed. For international child passport applications processed in the same period, the average processing time was 19.4 working days. Information is not held on the time between receipt of application and interview date as the date of interview can be subject to customer availability.</p><p>Her Majesty’s Passport Office must be fully satisfied that all appropriate checks have been completed successfully prior to the issuance of passport facilities. This is particularly important in relation to child applications as part of Her Majesty’s Passport Office responsibility to protect potentially vulnerable children, including those potentially at risk of child trafficking and to maintain the integrity of the British Passport.</p><p>These checks can require the provision of information from other agencies overseas – particularly in complex applications such as surrogacy cases.</p><p>Delays in the provision of this information to HMPO can lead to significantly extended timeframe in processing applications.</p><p> </p><p> </p> answering member constituency Old Bexley and Sidcup answering member printed James Brokenshire question first answered 15/07/2015 15:19:26 question first ministerially corrected 05/08/2015 14:35:08 answering member 1530 label Biography information for James Brokenshire previous answer version 15266 answering member constituency Old Bexley and Sidcup answering member printed James Brokenshire answering member 1530 label Biography information for James Brokenshire
	tabling member	4453 label Biography information for Tommy Sheppard

222480

	registered interest
	date	20/02/2015
	answering body	Department for Energy and Climate Change
	answering dept id	63
	answering dept short name	Energy and Climate Change
	answering dept sort name	Energy and Climate Change
	hansard heading	Energy: Prices
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Energy and Climate Change, what estimate he has made of the Rate of Return on Equity for each of the Distribution Network Operators under Distribution Price Control Review 5.
	tabling member constituency	Rutherglen and Hamilton West
	tabling member printed	Tom Greatrex
	uin	224816
	answer	answer is ministerial correction date of answer 25/02/2015 answer text <p>Ofgem are responsible for regulating the electricity Distribution Network Operators (DNOs) and the setting of the price control review. Ofgem’s latest estimate for the Rate of Return on Equity for each of the DNOs is in the attached table which covers the years 2010-11 to 2013-14. The last year of Distribution Price Control Review 5 (2014-15) is still on-going.</p><p> </p><p> </p><p> </p> answering member constituency West Suffolk answering member printed Matthew Hancock question first answered 25/02/2015 13:09:44 question first ministerially corrected 03/03/2015 09:58:49 answering member 4070 label Biography information for Matt Hancock attachment 1 file name Copy of RORE DNOs Excel.xlsx title Rate of Return on Equity for DNOs 2010-1 to 2013-4 previous answer version 46378 answering member constituency West Suffolk answering member printed Matthew Hancock answering member 4070 label Biography information for Matt Hancock
	tabling member	4047 label Biography information for Tom Greatrex

388981

	registered interest
	date	09/07/2015
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	Railways: Compensation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Transport, what information his Department holds on how much has been paid out by (a) Southern Rail and (b) all train operating companies to passengers for late running and cancellation compensation in each of the last five years.
	tabling member constituency	East Worthing and Shoreham
	tabling member printed	Tim Loughton
	uin	6383
	answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>The Department holds the information as set out in the table attached. Not all operators are required to provide such figures.</p><p> </p> answering member constituency Devizes answering member printed Claire Perry question first answered 14/07/2015 10:41:04 question first ministerially corrected 31/07/2015 10:06:34 answering member 3974 label Biography information for Claire Perry attachment 1 file name 006383 - TOC compensation 09_10-14_15 figures.pdf title UIN 6383 - TOC Compensation 09_10-14_15 previous answer version 13907 answering member constituency Devizes answering member printed Claire Perry answering member 3974 label Biography information for Claire Perry attachment 1 file name 006383 - TOC compensation 2010-15.pdf title UIN 6383 - TOC Compensation 2010-2015
	tabling member	114 label Biography information for Tim Loughton

347943

	registered interest
	date	02/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Human Papillomavirus: Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, to date, how many adverse reactions to (1) Cervarix, (2) Gardasil and (3) generic human papilloma virus vaccines have been reported to the Medicines and Healthcare products Regulatory Agency; for each category, how many of those reports are of serious adverse reactions; and what age-specific rate those figures represent.
	tabling member printed	The Countess of Mar
	uin	HL229
	answer	answer is ministerial correction date of answer 16/06/2015 answer text <p>A total of 8,243 suspected adverse drug reaction (ADR) reports with human papilloma virus (HPV) vaccines have been reported to the Medicines and Healthcare products Regulatory Agency (MHRA), via the Yellow Card Scheme, up to 3 June 2015.</p><p> </p><p> </p><p> </p><p>To date, more than 8 million doses of HPV vaccine have been given across the United Kingdom as part of the routine immunisation programme. The MHRA does not hold data on age-specific vaccine usage, and therefore age-specific reporting rates cannot be calculated.</p><p> </p><p> </p><p> </p><p>It is important to note that a Yellow Card report is not proof of a side effect occurring, but a suspicion by the reporter that the vaccine may have been the cause. Yellow Card data cannot be used as a reliable indicator of the frequency of suspected ADRs to vaccines or medicines. The level of ADR reporting may fluctuate between given years due to a variety of reasons such as a medicine being new (reporting rates are generally higher when a product is first introduced), stimulated interest/publicity and variations in exposure to the medicine.</p><p> </p><p> </p><p> </p><p>The possible known side effects, and the frequency, are listed in the product information which is provided with the vaccines. The vast majority of the 8,243 ADRs relate to the known risks of vaccination that are well-described in the available product information. The proportion of suspected ADRs for HPV vaccines that were reported as serious (32%) is less than the proportion reported as serious for other routinely used vaccines (68% overall) during the same time period. The expected benefits in protecting against HPV-related mortality and disease outweigh the known side effects of HPV vaccine.</p><p> </p><p> </p><p> </p><p>The following table provides a breakdown of UK suspected spontaneous ADRs received via the Yellow Card Scheme in association with the HPV vaccine. The MHRA does not hold data on age-specific vaccine usage, and therefore age-specific reporting rates cannot be calculated.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Vaccine Brand</p></td><td><p>Total number of reports</p></td><td><p>Number of serious reports (% of total)</p></td><td><p>Reporting rate per 1000 doses (serious reporting rates per 1000)</p></td></tr><tr><td><p>Cervarix</p></td><td><p>6,266</p></td><td><p>1,768 (28%)</p></td><td><p><ins class="ministerial">n/a **</ins><del class="ministerial">0.78 (0.22)</del></p></td></tr><tr><td><p>Gardasil</p></td><td><p>1,471</p></td><td><p>504 (34%)</p></td><td><p><ins class="ministerial">n/a **</ins><del class="ministerial">0.18 (0.06)</del></p></td></tr><tr><td><p>HPV Brand unspecified</p></td><td><p>507</p></td><td><p>326 (64%)</p></td><td><p><ins class="ministerial">n/a ** </ins><del class="ministerial">0.06 (0.04)</del></p></td></tr><tr><td><p>Total for Human Papilloma virus vaccines</p></td><td><p>*8,244</p></td><td><p>2,598 (32%)</p></td><td><p>1.03 (0.32)</p></td></tr></tbody></table><p> </p><p><em>Source:</em> MHRA sentinel database for adverse reactions.</p><p> </p><p>* It should be noted that the total number of reports received will not be equal to the totals in the table above as some reports of suspected adverse reactions may have included more than one vaccine.</p><p><ins class="ministerial">**Updated UK-wide brand-specific usage data are not available to MHRA at the time of writing based on a minimum of 8 million combined doses of Cervarix and Gardasil administered across the UK to date.</ins></p><p> </p><p><ins class="ministerial"> <p> </p><p> </p><p> </p></ins></p><p> </p><p> </p><p> </p><p> </p><p> </p><p>The seriousness criteria for ADR reporting were determined by a working group of the Council for International Organizations of Medical Sciences (CIOMS) and are defined as 6 possible categories which are explained on the Yellow Card. The MHRA asks reporters to select one of the following criteria by ticking the appropriate box on the Yellow Card: (1) patient died due to reaction; (2) life threatening; (3) resulted in hospitalisation or prolonged inpatient hospitalisation; (4) congenital abnormality; and (5) involved persistent or significant disability or incapacity; or (6) if the reaction was deemed medically significant. In addition to this, seriousness of reaction terms has also been defined by the MHRA in its medical dictionary. Therefore an ADR report can be serious because the reporter considers the reaction to be serious or because the reaction term itself is considered serious in the MHRA medical dictionary.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 16/06/2015 14:35:02 question first ministerially corrected 03/07/2015 14:01:13 answering member 127 label Biography information for Lord Prior of Brampton previous answer version 5462 answering member printed Lord Prior of Brampton answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	1861 label Biography information for The Countess of Mar

390599

	registered interest
	date	16/07/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Anaemia
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what action they are taking to address the problems associated with the late diagnosis of pernicious anaemia, in the light of the results of the survey published in the <i>British Nursing Journal</i> in April 2014.
	tabling member printed	The Countess of Mar
	uin	HL1539
	answer	answer is ministerial correction date of answer 24/07/2015 answer text <p>It is important that patients suffering from pernicious anaemia, the result of a vitamin B12 (cobalamin) deficiency, receive a prompt and appropriate diagnosis. Pernicious anaemia develops gradually, and can cause a range of symptoms, including fatigue, lethargy, feeling faint and headaches, which vary from patient to patient. Because of the gradual progression of the condition, the variety of symptoms, which are shared with a range of other conditions, diagnosis at early onset can be challenging.</p><p>To support the diagnosis of pernicious anaemia, the British Committee for Standards in Haematology (BCSH) has published <em>Guidelines for the diagnosis and treatment of Cobalamin and Folate disorders,</em> which sets out that cobalamin status is the recommended first line diagnostic test. However, the guidance states that there is no gold standard test for the condition and makes it clear that the clinical picture of a patient is the most important factor in assessing the significance of the test results. This means clinicians should take into account all of the symptoms the patent is experiencing, their medical history, age and other relevant factors when considering the implications of a patient’s cobalamin status. The BCSH guidance highlights the risk of neurological impairment if treatment is delayed.</p><p><br /> The BCSH operates independently of Department and NHS England and produces evidence based guidelines for both clinical and laboratory haematologists on the diagnosis and treatment of haematological disease, drawing on the advice of expert consultants and clinical scientists practicing in the United Kingdom. It would be for the BCSH, not the Department, to consider whether any adjustments to current best practice in the diagnosis and treatment of patients with pernicious anaemia were needed, including whether any new or additional tests were appropriate. A copy of the BCSH guidance document <del class="ministerial">has already been placed in the Library and</del> is attached.</p><p><br /> More general clinical guidance on the diagnosis and management of pernicious anaemia can also be found on the National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summaries website. This is a freely accessible online resource that covers the causes, symptoms, diagnosis and treatment of pernicious anaemia, as well as potential complications of the condition. In addition to this, NHS Choices provides similar, though less technical, information on pernicious anaemia for the public.</p> answering member printed Lord Prior of Brampton question first answered 24/07/2015 13:21:19 question first ministerially corrected 14/10/2015 11:21:08 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name colbalamin and folate disorders.pdf title BCSH Guidelines pernicious anaemia previous answer version 17459 answering member printed Lord Prior of Brampton answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name colbalamin and folate disorders.pdf title BCSH Guidelines pernicious anaemia
	tabling member	1861 label Biography information for The Countess of Mar